Literature DB >> 27119419

Impact of dialysis requirement on outcomes in tumor lysis syndrome.

Pranav S Garimella1, Poojitha Balakrishnan2, Natraj R Ammakkanavar3, Shanti Patel4, Achint Patel4, Ioannis Konstantinidis4, Narender Annapureddy5, Girish N Nadkarni4.   

Abstract

Tumor lysis syndrome (TLS) is a life threatening emergency due to destruction and massive release of intracellular metabolites from cancer cells often resulting in acute kidney injury (AKI), sometimes severe enough to require dialysis (AKI-D). The impact of dialysis requirement in AKI has not been explored. We utilized data from the Nationwide Inpatient Sample and using International Classification of Diseases, 9th Revision, diagnoses codes for TLS, AKI and dialysis, evaluated the incidence, risk factors and impact of AKI-D on mortality, adverse discharge and length of stay (LOS). Survey multivariable logistic regression was used to compute adjusted Odds Ratios (aOR and 95% confidence intervals (CI). An estimated 12% (2,919) of all TLS hospitalizations (n = 22 875) develop AK-D. After adjustment for confounders, AKI-D was associated with greater odds of mortality (aOR 1.98; (95% CI 1.60-2.45)), adverse discharge (aOR 1.63 (95% CI 1.19-2.24)) and longer LOS (19 vs 14.6 days; P < 0.01) compared with those without AKI-D. Further studies to evaluate the association of AKI-D on long-term outcomes in patients with TLS are needed.
© 2016 Asian Pacific Society of Nephrology.

Entities:  

Keywords:  acute kidney injury; dialysis; epidemiology; mortality; outcomes; tumor lysis syndrome

Mesh:

Year:  2017        PMID: 27119419     DOI: 10.1111/nep.12806

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  5 in total

1.  Tumor Lysis Syndrome in the Chronic Phase of Chronic Myeloid Leukemia Following COVID-19 Infection: A Case Report.

Authors:  Adnan Humam Waseem Hajjar; Shahem Abbarh; Abdulrahman Al-Mashdali; Awni Alshurafa; Mohammad Abu-Tineh; Hana Qasim; Khalid Ahmed; Mohamed A Yassin
Journal:  Cureus       Date:  2022-04-22

2.  Impact of daytime continuous veno-venous haemofiltration on treatment of paediatric tumour lysis syndrome.

Authors:  Yamei Wang; Jing Lu; Yuhong Tao
Journal:  J Int Med Res       Date:  2018-06-08       Impact factor: 1.671

3.  A New Challenging Strategy in the Prevention and Management of Tumor Lysis Syndrome in Patients with Chemo-Sensitive Hematological Malignancies.

Authors:  Ammar ELJack; Mohamad El Abdallah; Kadhim Al-Banaa; Kashif Chaudhry; Faisal Musa
Journal:  Case Rep Oncol Med       Date:  2019-05-19

4.  Critically ill cancer patient's resuscitation: a Belgian/French societies' consensus conference.

Authors:  Anne-Pascale Meert; Sebastian Wittnebel; Stéphane Holbrechts; Anne-Claire Toffart; Jean-Jacques Lafitte; Michael Piagnerelli; France Lemaitre; Olivier Peyrony; Laurent Calvel; Jean Lemaitre; Emmanuel Canet; Alexandre Demoule; Michael Darmon; Jean-Paul Sculier; Louis Voigt; Virginie Lemiale; Frédéric Pène; David Schnell; Etienne Lengline; Thierry Berghmans; Laurence Fiévet; Christiane Jungels; Xiaoxiao Wang; Ionela Bold; Aureliano Pistone; Adriano Salaroli; Bogdan Grigoriu; Dominique Benoit
Journal:  Intensive Care Med       Date:  2021-09-20       Impact factor: 17.440

5.  Relationship between uric acid and kidney function in adults at risk for tumor lysis syndrome.

Authors:  Heather P May; Kristin C Mara; Erin F Barreto; Nelson Leung; Thomas M Habermann
Journal:  Leuk Lymphoma       Date:  2021-06-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.